Pimavanserin (Nuplazid)
NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
Each tablet contains 17mg of pimavanserin.
- Trade name: Nuplazid
- Manufacturer: Acadia Pharmaceuticals.
- Presentation: Tablet
- Strength: 17mg
- Pack Size: 60 Tablets
- Pack Insert: yes
- National Drug Code: NA
- Marketing Authorization Holder: No
- Manufacturing License: NDC 63090-170-60
View this product at gnhindia.com